Tag Archives: patent attorney

Time For Myriad To Fight Another Day

Put another way, it is time for Jones Day to click their well-polished heels and go home. Today, the U.S. Government filed an amicus brief largely supporting the arguments by AMP/ACLU that isolated DNA is essentially the same molecule after … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , , , , , | 2 Comments

Supreme Court to Review Monsanto v. Bowman

On Friday, Oct 5th, the Supreme Court granted cert. to review the Fed. Cir.’s decision in Monsanto Co. v. Bowman, App. no. 2010-1068 (Fed. Cir. September 21, 2011). (A copy of the decision is at the end of this post.) … Continue reading

Posted in Ag Biotechnology, Exhaustion of Rights | Tagged , , , , , , , , , , , , , , | Leave a comment

Federal Circuit Knocks Outside the Box’s Inequitable Conduct Charges Out of the Box

The following is a guest post from Schwegman Lundberg & Woessner’s associate Ricardo Moran. The issues on appeal were whether Travel Caddy, Inc. had committed inequitable conduct for: (i) not disclosing the existence of the litigation on U.S. Patent No. … Continue reading

Posted in Inequitable Conduct/Rule 56 | Tagged , , , , , , , , , , , | 1 Comment

Lilly Files Amicus Brief in Myriad Remand – With Friends Like This…

Following its reversal of the Fed. Cir.’s decision in Mayo v. Prometheus (“Mayo”), the Supreme Court GVR’d in response to AMP’s (read: ACLU’s) appeal of Myriad’s claims to isolated DNA sequences and to a method of screening potential anti-cancer drugs … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , , , | Leave a comment